ES2078264T3 - Reactivos standard para la cuantificacion de vih p24. - Google Patents

Reactivos standard para la cuantificacion de vih p24.

Info

Publication number
ES2078264T3
ES2078264T3 ES90110106T ES90110106T ES2078264T3 ES 2078264 T3 ES2078264 T3 ES 2078264T3 ES 90110106 T ES90110106 T ES 90110106T ES 90110106 T ES90110106 T ES 90110106T ES 2078264 T3 ES2078264 T3 ES 2078264T3
Authority
ES
Spain
Prior art keywords
hiv
antigen
panel
quantitation
purified viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90110106T
Other languages
English (en)
Inventor
James Lawrence Stewart
Straw Regina H Mc
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23418932&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2078264(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of ES2078264T3 publication Critical patent/ES2078264T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

EL INVENTO ACTUAL SE DIRIGE A METODOS DE INMUNOENSAYO MEJORADO, Y COMPOSICIONES Y KITS PARA DESARROLLAR LOS METODOS, PARA CUANTIFICACION DEL ANTIGENO HIV P24 EN UNA MUESTRA BIOLOGICA. EL METODO SUPONE EL CONTACTO DE UNA MUESTRA CON UN ANTICUERPO ESPECIFICO PARA EL ANTIGENO HIV P24, MEDIANTE EL QUE SE FORMA UN COMPLEJO ANTIGENO-ANTICUERPO DETECTABLE, Y QUE CUANTIFICA LA CANTIDAD DEL COMPLEJO FORMADO, MEDIANTE EL EMPLEO DE UN PANEL DE CUANTIFICACION COMO UN ESTANDAR CON EL CUAL SE PUEDE COMPARAR LA CANTIDAD DEL COMPLEJO FORMADO. EL METODO SUPONE LA UTILIZACION DE ANTIGENO PURIFICADO HIV P24 EN EL PANEL DE CUANTIFICACION. DE FORMA PREFERIBLE, EL PANEL DE CUANTIFICACION COMPRENDE ESTANDARES LIOFILIZADOS QUE CONTIENEN ANTIGENO VIRAL DE INMUNOAFINIDADPURIFICADA P24. LA COMPOSICION INCLUYE VIRAL PURIFICADO HIV P24 Y UN AMORTIGUADOR. EL KIT INCLUYE UN PANEL DE COMPOSICIONES VIRALES PURIFICADAS HIV P24.
ES90110106T 1989-06-02 1990-05-28 Reactivos standard para la cuantificacion de vih p24. Expired - Lifetime ES2078264T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36066189A 1989-06-02 1989-06-02

Publications (1)

Publication Number Publication Date
ES2078264T3 true ES2078264T3 (es) 1995-12-16

Family

ID=23418932

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90110106T Expired - Lifetime ES2078264T3 (es) 1989-06-02 1990-05-28 Reactivos standard para la cuantificacion de vih p24.

Country Status (8)

Country Link
EP (1) EP0400548B1 (es)
JP (1) JPH0329856A (es)
KR (1) KR910001378A (es)
AT (1) ATE126600T1 (es)
AU (1) AU639457B2 (es)
CA (1) CA2018098A1 (es)
DE (1) DE69021640T2 (es)
ES (1) ES2078264T3 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9487837B2 (en) 2008-10-06 2016-11-08 Morehouse School Of Medicine Exosome-mediated diagnosis of hepatitis virus infections and diseases
US10545149B2 (en) * 2008-10-06 2020-01-28 Morehouse School Of Medicine Detection of HIV-related proteins in urine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4121905A (en) * 1977-08-22 1978-10-24 Jonas Maurukas Process for preparing biological compositions for use as reference controls in diagnostic analyses
US4195072A (en) * 1978-07-05 1980-03-25 Abbott Laboratories Stabilized platelet factor 4 immunoassay standards
NZ228756A (en) * 1984-04-23 1990-10-26 Us Health Detection of hiv antigen using competition immune assay or western blot assay
US4748110A (en) * 1985-09-25 1988-05-31 Abbott Laboratories Immunoassay for HTLV-III antigens
AU612760B2 (en) * 1987-11-06 1991-07-18 Coulter Corporation Enzyme immunoassay for detecting hiv antigens in human sera

Also Published As

Publication number Publication date
KR910001378A (ko) 1991-01-30
EP0400548A2 (en) 1990-12-05
EP0400548A3 (en) 1991-12-11
ATE126600T1 (de) 1995-09-15
JPH0329856A (ja) 1991-02-07
AU639457B2 (en) 1993-07-29
DE69021640T2 (de) 1996-04-04
DE69021640D1 (de) 1995-09-21
AU5603190A (en) 1990-12-06
EP0400548B1 (en) 1995-08-16
CA2018098A1 (en) 1990-12-02

Similar Documents

Publication Publication Date Title
KR890702038A (ko) 인간 혈청에서의 hiv 항원 검출용 효소 면역 분석법
DE69132238D1 (de) Verfahren zur Stabilisierung von Enzym-Konjugaten
ATE105635T1 (de) Extraktionszusammensetzung, testsatz und deren verwendung zum nachweis von herpes-simplexantigen.
KR910001379A (ko) 핵산 결정 방법
ES2023868B3 (es) Procedimiento de determinacion inmunometrico
ES2078264T3 (es) Reactivos standard para la cuantificacion de vih p24.
BR9100924A (pt) Linha de celulas de hibridoma,mutantes,anticorpos,processo para a preparacao de uma linha de celulas de hibridoma,processo para a preparacao de anticorpos,processo e agente para a prova imunologica de metolacloro,derivado de metolacloro e processo para sua preparacao
DE3785567D1 (de) Immunologischer testkit.
KR960024367A (ko) N-펩티드의 샌드위치 면역학적 측정법
KR850008620A (ko) Atl 바이러스 항체의 측정방법 및 시약
NO884131D0 (no) Agglutineringsreagens og dets anvendelse for detektering av antigene antistoffer eller andre analyter.
KR940000870A (ko) β-N- 아세틸글루코사미니다제의 샌드위치 면역 측정법 및 그 측정법에 사용된 모노클론 항체
IT1237809B (it) Metodo per la determinazione qualitativa e quantitativa di anticorpi diretti contro antigeni batterici attraverso la misurazione fotometrica dell'agglutinazione.
FR2689246B1 (fr) Procede immunochimique de detection de l'origine d'une substance produite par genie genetique et reactifs pour sa mise en óoeuvre.
ATE110470T1 (de) Immuntestverfahren von chondrocalcin.
NO179468C (no) Fremgangsmåte for å bestemme antistoff og assayreagenssett for dette

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 400548

Country of ref document: ES